报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2025-03-31 | 95.57% | -1.95% | -1.89% | 2/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
2024-12-31 | 97.41% | 0.97% | -0.32% | 3/159 | 51.8% | 首药控股 | 98.96% | 行业排名> |
2024-09-30 | 97.73% | 2.08% | 0.07% | 1/159 | 22.98% | 迪哲医药 | 97.73% | 行业排名> |
2024-06-30 | 97.66% | 694.34% | 0.19% | 2/159 | 33.39% | 百利天恒 | 97.99% | 行业排名> |
2024-03-31 | 97.47% | 2% | 1.03% | 3/159 | 51.73% | 百利天恒 | 98.92% | 行业排名> |
2023-12-31 | 96.48% | 676.79% | 0.78% | 3/159 | 51.53% | 迈威生物 | 98.93% | 行业排名> |
2023-09-30 | 95.73% | 674.14% | 670.78% | 3/159 | 32.76% | 迈威生物 | 99.59% | 行业排名> |
2021-12-31 | 12.42% | -0.41% | 0.44% | 147/159 | 55.21% | 迈威生物 | 99.8% | 行业排名> |
2021-09-30 | 12.37% | 2% | 0.59% | 131/159 | 47.01% | 迈威生物 | 99.46% | 行业排名> |
2021-06-30 | 12.29% | 2% | -1.42% | 139/159 | 47.45% | 迈威生物 | 99.75% | 行业排名> |
2020-12-31 | 12.47% | 2% | 2% | 141/159 | -144.37% | 迈威生物 | 99.67% | 行业排名> |